Fragment-based discovery, dynamics simulation and pharmacological study of 2-amino-pyrimidine derivative as HIPK2 inhibitor
- 9 October 2025
- journal article
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 421, 111771
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81773640)
This publication has 31 references indexed in Scilit:
- Sodium-glucose co-transporter 2 inhibitors in patients with chronic kidney diseasePharmacology & Therapeutics, 2022
- Inhibition of HIPK2 protects stress-induced pathological cardiac remodelingEBioMedicine, 2022
- Wound healing, fibroblast heterogeneity, and fibrosisCell Stem Cell, 2022
- Identification of selective homeodomain interacting protein kinase 2 inhibitors, a potential treatment for renal fibrosisBioorganic Chemistry, 2022
- Highly selective inhibitors of protein kinases CLK and HIPK with the furo[3,2-b]pyridine coreEuropean Journal of Medicinal Chemistry, 2021
- The antihelmenthic phosphate niclosamide impedes renal fibrosis by inhibiting homeodomain-interacting protein kinase 2 expressionKidney International, 2017
- Macrophages in Tissue Repair, Regeneration, and FibrosisImmunity, 2016
- Multiwfn: A multifunctional wavefunction analyzerJournal of Computational Chemistry, 2011
- p53 and apoptosisSeminars in Cancer Biology, 1998
- THE weighted histogram analysis method for free‐energy calculations on biomolecules. I. The methodJournal of Computational Chemistry, 1992